Zimmer Biomet Holdings (ZBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 238,300 | 705,100 | 567,200 | 336,000 | 182,600 |
| Depreciation Amortization | 270,000 | 1,093,800 | 809,800 | 526,200 | 254,400 |
| Income taxes - deferred | N/A | -87,200 | N/A | N/A | N/A |
| Accounts receivable | 14,500 | -127,300 | -15,600 | -18,600 | -18,800 |
| Other Working Capital | -173,300 | -104,900 | -263,500 | -142,100 | -73,900 |
| Other Operating Activity | 9,900 | 217,600 | 81,800 | 59,500 | 38,500 |
| Operating Cash Flow | $359,400 | $1,697,100 | $1,179,700 | $761,000 | $382,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -113,500 | -525,000 | -375,900 | -234,900 | -104,300 |
| Net Acquisitions | N/A | -1,393,200 | -1,268,700 | -1,226,300 | N/A |
| Purchase Sale Intangibles | -39,000 | -52,400 | N/A | -32,400 | -2,400 |
| Other Investing Activity | -45,500 | -57,500 | -9,100 | -29,200 | -1,700 |
| Investing Cash Flow | $-159,000 | $-1,975,700 | $-1,653,700 | $-1,490,400 | $-106,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,492,100 | 2,492,100 | 1,968,100 | 1,748,100 |
| Debt Repayment | N/A | -1,463,000 | -863,000 | -863,000 | -863,000 |
| Common Stock Issued | 12,300 | 39,700 | 38,000 | 17,100 | 16,700 |
| Common Stock Repurchased | -250,100 | -487,000 | -237,000 | -237,000 | -229,800 |
| Dividend Paid | -46,900 | -190,300 | -142,800 | -95,300 | -47,800 |
| Other Financing Activity | -84,500 | -65,500 | -64,300 | -50,700 | -48,800 |
| Financing Cash Flow | $-369,200 | $326,000 | $1,223,000 | $739,200 | $575,400 |
| Exchange Rate Effect | 1,100 | 19,000 | 18,200 | 21,600 | 7,000 |
| Beginning Cash Position | 591,900 | 525,500 | 525,500 | 525,500 | 525,500 |
| End Cash Position | 424,200 | 591,900 | 1,292,700 | 556,900 | 1,384,500 |
| Net Cash Flow | $-167,700 | $66,400 | $767,200 | $31,400 | $859,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 359,400 | 1,697,100 | 1,179,700 | 761,000 | 382,800 |
| Capital Expenditure | -113,500 | -525,000 | -375,900 | -234,900 | -104,300 |
| Free Cash Flow | 245,900 | 1,172,100 | 803,800 | 526,100 | 278,500 |